azobenzene has been researched along with Neoplasms in 39 studies
azobenzene: photosensor molecule known to undergo reversible isomerization from trans to cis on illumination with photons of appropriate wavelength; RN given refers to cpd without isomeric designation; structure
(E)-azobenzene : The (E)-isomer of azobenzene.
(Z)-azobenzene : The (Z)-isomer of azobenzene.
azobenzene : A molecule whose structure comprises two phenyl rings linked by a N=N double bond; the parent compound of the azobenzene class of compounds.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The azobenzene moiety has been integrated within some chemotherapeutic drugs to realize photo-triggered activation of drug cytotoxicity." | 2.66 | Azobenzene Photoswitch for Isomerization-Dependent Cancer Therapy via Azo-Combretastatin A4 and Phototrexate. ( Guo, T; Mulatihan, D; Zhao, Y, 2020) |
| "The lack of selectivity of anticancer drugs limits current chemotherapy." | 1.91 | Visible-Light-Controlled Histone Deacetylase Inhibitors for Targeted Cancer Therapy. ( Josa-Culleré, L; Llebaria, A, 2023) |
| "A therapy of cancer cells: Two-photon-triggered camptothecin delivery with nanoimpellers was studied in MCF-7 breast cancer cells." | 1.39 | Two-photon-triggered drug delivery in cancer cells using nanoimpellers. ( Blanchard-Desce, M; Charnay, C; Cheminet, N; Croissant, J; Derrien, G; Durand, JO; Gallud, A; Garcia, M; Gary-Bobo, M; Guardado-Alvarez, TM; Jarrosson, T; Lu, J; Maynadier, M; Mongin, O; Nyalosaso, JL; Peindy N'dongo, H; Raehm, L; Serein-Spirau, F; Tamanoi, F; Tarn, D; Zink, JI, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 23 (58.97) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (17.95) | 24.3611 |
| 2020's | 9 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, R | 1 |
| Elf, S | 1 |
| Shan, C | 1 |
| Kang, HB | 1 |
| Ji, Q | 1 |
| Zhou, L | 1 |
| Hitosugi, T | 1 |
| Zhang, L | 1 |
| Zhang, S | 1 |
| Seo, JH | 1 |
| Xie, J | 1 |
| Tucker, M | 1 |
| Gu, TL | 1 |
| Sudderth, J | 1 |
| Jiang, L | 1 |
| Mitsche, M | 1 |
| DeBerardinis, RJ | 1 |
| Wu, S | 1 |
| Li, Y | 1 |
| Mao, H | 1 |
| Chen, PR | 1 |
| Wang, D | 1 |
| Chen, GZ | 1 |
| Hurwitz, SJ | 1 |
| Lonial, S | 1 |
| Arellano, ML | 1 |
| Khoury, HJ | 1 |
| Khuri, FR | 1 |
| Lee, BH | 1 |
| Lei, Q | 1 |
| Brat, DJ | 1 |
| Ye, K | 1 |
| Boggon, TJ | 1 |
| He, C | 1 |
| Kang, S | 1 |
| Fan, J | 1 |
| Chen, J | 1 |
| Yang, DC | 2 |
| Wen, LF | 2 |
| Du, L | 1 |
| Luo, CM | 2 |
| Lu, ZY | 1 |
| Liu, JY | 2 |
| Lin, Z | 2 |
| Yang, XZ | 1 |
| Josa-Culleré, L | 1 |
| Llebaria, A | 1 |
| Liu, Y | 1 |
| Dong, W | 1 |
| Ma, Y | 1 |
| Dou, J | 1 |
| Jiang, W | 1 |
| Wang, L | 2 |
| Wang, Q | 2 |
| Li, S | 1 |
| Wang, Y | 1 |
| Li, M | 1 |
| Thomas, T | 1 |
| Govindharaj, M | 1 |
| Unni, HN | 1 |
| Kumari, N | 1 |
| Rath, SN | 1 |
| Chaix, A | 1 |
| Cueto-Diaz, E | 1 |
| Dominguez-Gil, S | 1 |
| Spiteri, C | 1 |
| Lichon, L | 1 |
| Maynadier, M | 2 |
| Dumail, X | 1 |
| Aggad, D | 1 |
| Delalande, A | 1 |
| Bessière, A | 1 |
| Pichon, C | 1 |
| Chiappini, C | 1 |
| Sailor, MJ | 1 |
| Bettache, N | 1 |
| Gary-Bobo, M | 2 |
| Durand, JO | 2 |
| Nguyen, C | 1 |
| Cunin, F | 1 |
| Zhou, F | 1 |
| Fu, T | 1 |
| Huang, Q | 1 |
| Kuai, H | 1 |
| Mo, L | 1 |
| Liu, H | 1 |
| Peng, Y | 1 |
| Han, D | 1 |
| Zhao, Z | 1 |
| Fang, X | 1 |
| Tan, W | 1 |
| Mulatihan, D | 1 |
| Guo, T | 1 |
| Zhao, Y | 1 |
| Zhang, T | 1 |
| Liu, Z | 1 |
| Aslan, H | 1 |
| Zhang, C | 1 |
| Yu, M | 1 |
| Heintze, L | 1 |
| Schmidt, D | 1 |
| Rodat, T | 1 |
| Witt, L | 1 |
| Ewert, J | 1 |
| Kriegs, M | 1 |
| Herges, R | 1 |
| Peifer, C | 1 |
| Blanco, B | 1 |
| Palasis, KA | 1 |
| Adwal, A | 1 |
| Callen, DF | 1 |
| Abell, AD | 1 |
| Bai, Y | 1 |
| Liu, CP | 1 |
| Song, X | 1 |
| Zhuo, L | 1 |
| Bu, H | 1 |
| Tian, W | 1 |
| Croissant, J | 1 |
| Gallud, A | 1 |
| Peindy N'dongo, H | 1 |
| Nyalosaso, JL | 1 |
| Derrien, G | 1 |
| Charnay, C | 1 |
| Raehm, L | 1 |
| Serein-Spirau, F | 1 |
| Cheminet, N | 1 |
| Jarrosson, T | 1 |
| Mongin, O | 1 |
| Blanchard-Desce, M | 1 |
| Garcia, M | 1 |
| Lu, J | 1 |
| Tamanoi, F | 1 |
| Tarn, D | 1 |
| Guardado-Alvarez, TM | 1 |
| Zink, JI | 1 |
| Hansen, MJ | 1 |
| Velema, WA | 1 |
| de Bruin, G | 1 |
| Overkleeft, HS | 1 |
| Szymanski, W | 1 |
| Feringa, BL | 1 |
| Yao, C | 1 |
| Wang, P | 1 |
| Li, X | 1 |
| Hu, X | 1 |
| Hou, J | 1 |
| Zhang, F | 1 |
| MAYER, RL | 1 |
| MILLER, JA | 4 |
| KLINE, BE | 1 |
| RUSCH, HP | 1 |
| GIESE, JE | 1 |
| CLAYTON, CC | 1 |
| MILLER, EC | 1 |
| WHITE, FR | 1 |
| WHITE, J | 1 |
| HOCH-LIGETI, C | 3 |
| CORTELL, R | 1 |
| HARRIS, PN | 3 |
| KRAHL, ME | 2 |
| CLOWES, GH | 2 |
| SHARPLESS, GR | 1 |
| MORI, K | 1 |
| MOMOKI, S | 1 |
| FARE, G | 1 |
| HOWELL, JS | 1 |
| OGAWA, Y | 1 |
| TANAKA, A | 1 |
| IMAGI, S | 1 |
| NAITO, N | 1 |
| MIYAZAKI, O | 1 |
| MAKINO, K | 1 |
| MUELLER, GC | 1 |
| DRUCKREY, H | 1 |
| HAMPERL, H | 1 |
| PRICE, JM | 1 |
| MARX, W | 1 |
| KENSLER, CJ | 1 |
| Tindall, JP | 1 |
3 reviews available for azobenzene and Neoplasms
| Article | Year |
|---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; | 2015 |
Azobenzene Photoswitch for Isomerization-Dependent Cancer Therapy via Azo-Combretastatin A4 and Phototrexate.
Topics: Antineoplastic Agents; Azo Compounds; Humans; Isomerism; Neoplasms; Stilbenes | 2020 |
Chloracne and chloracnegens.
Topics: 2,4-Dichlorophenoxyacetic Acid; 2,4,5-Trichlorophenoxyacetic Acid; Acne Vulgaris; Agent Orange; Anil | 1985 |
36 other studies available for azobenzene and Neoplasms
| Article | Year |
|---|---|
A Hypoxia-Activated Prodrug Conjugated with a BODIPY-Based Photothermal Agent for Imaging-Guided Chemo-Photothermal Combination Therapy.
Topics: Azo Compounds; Boron; Boron Compounds; Camptothecin; Cell Line, Tumor; Humans; Hyperthermia, Induced | 2022 |
A promising strategy for synergistic cancer therapy by integrating a photosensitizer into a hypoxia-activated prodrug.
Topics: Camptothecin; Cell Line, Tumor; Humans; Hypoxia; Nanoparticles; Neoplasms; Photochemotherapy; Photos | 2022 |
Visible-Light-Controlled Histone Deacetylase Inhibitors for Targeted Cancer Therapy.
Topics: Antineoplastic Agents; Histone Deacetylase Inhibitors; Humans; Light; Neoplasms | 2023 |
Nanomedicines with high drug availability and drug sensitivity overcome hypoxia-associated drug resistance.
Topics: Cell Line, Tumor; Cisplatin; Drug Resistance; Humans; Hyaluronic Acid; Hypoxia; Nanomedicine; Nanopa | 2023 |
On-chip mixing of cancer cells and drug using LED enabled 2D opto-wetting droplet platforms.
Topics: Antineoplastic Agents; Azo Compounds; Neoplasms; Paclitaxel; Surface Tension | 2023 |
Two-Photon Light Trigger siRNA Transfection of Cancer Cells Using Non-Toxic Porous Silicon Nanoparticles.
Topics: Cell Line, Tumor; Humans; Nanoparticles; Neoplasms; Porosity; RNA, Small Interfering; Silicon; Trans | 2023 |
Hypoxia-Activated PEGylated Conditional Aptamer/Antibody for Cancer Imaging with Improved Specificity.
Topics: Aptamers, Nucleotide; Azo Compounds; Humans; K562 Cells; Models, Molecular; Neoplasms; Optical Imagi | 2019 |
NIR-responsive reversible phase transition of supramolecular hydrogels for tumor treatment.
Topics: alpha-Cyclodextrins; Animals; Antineoplastic Agents; Azo Compounds; Doxorubicin; Drug Carriers; Drug | 2020 |
Photoswitchable Azo- and Diazocine-Functionalized Derivatives of the VEGFR-2 Inhibitor Axitinib.
Topics: Axitinib; Azo Compounds; Carbon; Humans; Isomerism; Light; Neoplasms; Photochemical Processes; Stilb | 2020 |
Azobenzene-containing photoswitchable proteasome inhibitors with selective activity and cellular toxicity.
Topics: Antineoplastic Agents; Azo Compounds; Cell Line, Tumor; Cell Proliferation; Humans; Isomerism; Neopl | 2017 |
Photo- and pH- Dual-Responsive β-Cyclodextrin-Based Supramolecular Prodrug Complex Self-Assemblies for Programmed Drug Delivery.
Topics: Antibiotics, Antineoplastic; Azo Compounds; beta-Cyclodextrins; Cell Survival; Delayed-Action Prepar | 2018 |
Two-photon-triggered drug delivery in cancer cells using nanoimpellers.
Topics: Azo Compounds; Drug Delivery Systems; Humans; Nanoparticles; Neoplasms | 2013 |
Proteasome inhibitors with photocontrolled activity.
Topics: Antineoplastic Agents; Azo Compounds; Cell Survival; Drug Design; HeLa Cells; Humans; Light; Neoplas | 2014 |
Near-Infrared-Triggered Azobenzene-Liposome/Upconversion Nanoparticle Hybrid Vesicles for Remotely Controlled Drug Delivery to Overcome Cancer Multidrug Resistance.
Topics: Azo Compounds; Doxorubicin; Drug Delivery Systems; Drug Liberation; Drug Resistance, Multiple; Human | 2016 |
Aromatic amines and azo-dyes in allergy and cancer.
Topics: Amines; Anaphylaxis; Azo Compounds; Coloring Agents; Humans; Hypersensitivity; Neoplasms | 1948 |
The inhibition of the carcinogenicity of p-dimethyl-aminoazobenzene by certain detergents and the effect of diet on the levels of azo dyes in rat tissues.
Topics: Animals; Azo Compounds; Coloring Agents; Detergents; Diet; Dietetics; Neoplasms; Rats | 1946 |
The effect of certain diets on hepatic tumor formation due to m-methyl-p-dimethylaminoazobenzene and o'methyl-p-dimethylaminoazobenzene.
Topics: Azo Compounds; Diet; Dietetics; Liver; Liver Neoplasms; Neoplasms; p-Dimethylaminoazobenzene | 1946 |
The metabolism and carcinogenicity of p-dimethylaminoazobenzene and related compounds in the rat.
Topics: Animals; Azo Compounds; Neoplasms; p-Dimethylaminoazobenzene; Rats | 1947 |
Effect of cystine per se on the formation of hepatomas in rats following the ingestion of p-dimethylamino-azobenzene.
Topics: Animals; Azo Compounds; Carcinoma, Hepatocellular; Cystine; Liver Neoplasms; Neoplasms; Rats | 1946 |
Changes in the succinoxidase activity of livers from rats during the development of hepatic tumors on feeding para-dimethyl-aminoazobenzene.
Topics: Animals; Azo Compounds; Liver; Liver Neoplasms; Neoplasms; Oxidoreductases; p-Aminoazobenzene; Rats | 1947 |
The production of tumors in the livers of rats fed in-methyl-para-dimethylaminoazobenzene.
Topics: Animals; Azo Compounds; Liver Neoplasms; Neoplasms; p-Dimethylaminoazobenzene; Rats | 1947 |
p-Dimethylaminoazobenzene carcinogenesis with purified diets varying in content of cysteine, cystine, liver extract, protein, riboflavin, and other factors.
Topics: Azo Compounds; Carcinogenesis; Cysteine; Cystine; Diet; Liver Extracts; Neoplasms; p-Dimethylaminoaz | 1947 |
The effect of biotin upon para-dimethylaminoazobenzene carcinogenesis.
Topics: Azo Compounds; Biotin; Carcinogenesis; Female; Humans; Neoplasms; p-Dimethylaminoazobenzene; Parity; | 1947 |
The effect of diet containing dried egg albumin upon para-dimethylaminoazobenzene carcinogenesis.
Topics: Albumins; Azo Compounds; Carcinogenesis; Diet; Neoplasms; p-Dimethylaminoazobenzene; Proteins | 1947 |
The effects of copper on liver tumor induction by p-dimethylaminoazobenzene.
Topics: Animals; Azo Compounds; Copper; Liver; Liver Neoplasms; Neoplasms; Neoplasms, Experimental; p-Dimeth | 1946 |
Effect of fresh milk on the production of hepatic tumors in rats by dimethylaminoazobenzene.
Topics: Animals; Azo Compounds; Liver Neoplasms; Milk; Neoplasms; p-Dimethylaminoazobenzene; Rats | 1946 |
Catalase studies on rats during p-dimethylamino azobenzene carcinogenesis.
Topics: Animals; Azo Compounds; Carcinogenesis; Catalase; Liver Neoplasms; Neoplasms; Oxidoreductases; Rats | 1952 |
THE EFFECT OF DIETARY COPPER ON RAT CARCINOGENESIS BY 3-METHOXY DYES. I. TUMORS INDUCED AT VARIOUS SITES BY FEEDING 3-METHOXY-4-AMINOAZOBENZENE AND ITS N-METHYL DERIVATIVE.
Topics: Azo Compounds; Carcinogenesis; Carcinogens; Coloring Agents; Copper; Diet; Ear Canal; Liver Neoplasm | 1964 |
On the development of multiple visceral cancers in guineapigs through excess nutrition and dimethylaminoazobenzol.
Topics: Azo Compounds; Carcinogens; Dietetics; Humans; Neoplasms; Nutritional Sciences; Nutritional Status; | 1950 |
Development of visceral cancer in pigeon and fowl caused by surplus nutrition and butter yellow, particularly on generation of hepatoma.
Topics: Animals; Azo Compounds; Birds; Carcinogens; Carcinoma, Hepatocellular; Columbidae; Dietetics; Liver | 1950 |
The reductive cleavage of 4-dimethylaminoazobenzene by rat liver: reactivation of carbon dioxide-treated homogenates by riboflavin-adenine dinucleotide.
Topics: Adenine; Azo Compounds; Carbon Dioxide; Flavin-Adenine Dinucleotide; Liver; Neoplasms; p-Dimethylami | 1950 |
[Food dyes and cancer; experiments with 2-4-dioxyazobenzol-2'-4'-disulfonate of sodium (chrysoin)].
Topics: Anions; Azo Compounds; Coloring Agents; Food; Neoplasms; Sodium | 1950 |
Studies on the intracellular composition of liver and liver tumor from rats fed 4-dimethylaminoazobenzene.
Topics: Animals; Azo Compounds; Cytoplasm; Liver; Liver Neoplasms; Neoplasms; p-Dimethylaminoazobenzene; Rat | 1949 |
The influence of normal and cancer blood on tyrosinase activity in vitro.
Topics: Azo Compounds; Blood; Enzymes; Hematologic Neoplasms; Humans; In Vitro Techniques; Monophenol Monoox | 1949 |
Primary pancreatic tumours in rats fed p-dimethylaminoazobenzene.
Topics: Animals; Azo Compounds; Neoplasms; p-Dimethylaminoazobenzene; Pancreas; Pancreatic Neoplasms; Rats | 1949 |
The influence of diet on the riboflavin content and the ability of rat liver slices to destroy the carcinogen N,N-dimethyl-p-amino azobenzene.
Topics: Animals; Azo Compounds; Carcinogens; Diet; Liver; Neoplasms; Rats; Riboflavin | 1949 |